News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Merck & Co., Inc. Vaccine Wins OK for Vaginal Cancer
September 15, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON (Reuters) - U.S. health regulators have approved Merck and Co's Gardasil vaccine to protect women against rare vaginal and vulvar cancers, the Food and Drug Administration said on Friday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Merck & Co.
MORE ON THIS TOPIC
Huntington’s disease
FDA Minutes Confirm Challenging Path Ahead for UniQure’s Huntington’s Gene Therapy
December 4, 2025
·
2 min read
·
Heather McKenzie
Policy
FDA Eyes Higher User Fees for Companies Holding Phase I Studies Abroad
December 4, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
December 4, 2025
·
2 min read
·
Tristan Manalac
Regulatory
COVID Contrarian Tracy Beth Høeg Named as FDA’s Acting CDER Chief
December 4, 2025
·
2 min read
·
Tristan Manalac